Nuvo Research Inc. is a publicly traded, pharmaceutical company headquartered in Mississauga, Ontario with manufacturing facilities located in Varennes, Quebec and Wanzleben, Germany, and research and development facilities in San Diego, California and Leipzig, Germany.
Nuvo is focused on the research and development of drug products using its topical and transdermal drug delivery technologies. The Company develops drugs based on two technology platforms: transdermal drug delivery and immune system regulation.
Nuvo markets two products Pennsaid®, a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis of the knee and Oxoferin™, a topical wound healing agent.
In June 2009, Nuvo entered into a license and development agreement with Mallinckrodt Inc., a subsidiary of Covidien (NYSE:COV), granting it exclusive rights to market and sell Pennsaid, and its follow-on product, Pennsaid Plus, in the United States.
In November 2009, the U.S. Food and Drug Administration (FDA) approved Nuvo's New Drug Application for Pennsaid allowing Covidien to market and sell Pennsaid in the U.S which they plan to commence in the first half of 2010.
Nuvo is traded on the TSX exchange under NRI.TO and under the Pink Sheets exchange under NRIFF.
Shares Outstanding: 394 Million
Investors Presentation: 20 Feb 2010
Insider Holdings: Click here for most recent filings
All insider transactions can be viewed here by insider name. By clicking here you must enter the Insider Name and search criteria
Franklin Templeton Investments holdings as of December 31 2009. Click here for details Franklin Templeton Recent Holdings
NUVO RESEARCH INC 3,441,200 $1,059,783 N/A N/A
NUVO RESEARCH INC 3,443,000 $1,060,338 N/A N/A
Recent US filings. Click here to see info from mffais
|Fund ||Shares held |
|Sa International Small Company Fund ||447,000 |
|Janney Montgomery Scott Llc ||10,000 |
|Penn Mutual Life Insurance Co ||10,000 |
|Dfa Investment Trust Co ||223,500 |
Latest Filings: Click here for more past filings
4th Quarter ending December 31st 2009. Nuvo Announces Fourth Quarter & Year-End Results
3rd Quarter ending September 30th 2009. Nuvo Announces Third Quarter Results
For news prior to 2009 click here
For all Sedar filings click here
NOTE: Do not buy just because of the information on this board. Do your own Due Diligence before investing in this stock.